merged_fda-journavx-suzetrigine-vertex-opioids.txt
<question_number>1</question_number>
<answer>N/A</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>N/A</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>0</answer>

<other>The article states that Journavx is nonaddictive, so the projected number of patients per year who might develop a dependency on Journavx is 0.</other>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>N/A</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>N/A</answer>

<question_number>10</question_number>
<answer>N/A</answer>

<question_number>11</question_number>
<answer>lumbosacral radiculopathy</answer>

<other>The article mentions that Vertex found suzetrigine was no better than placebo in those with pinched spinal nerves, which is related to lumbosacral radiculopathy.</other>

<question_number>12</question_number>
<answer>approximately 2250</answer>

<other>The article mentions two large clinical trials with approximately 1,000 patients each and a 250-person study, making a total of approximately 2250 patients.</other>

<question_number>13</question_number>
<answer>Nav1.7 and Nav1.8</answer>

<other>The article states that Dr. Waxman discovered two sodium channels, Nav1.7 and Nav1.8, that are active outside the brain and critical for peripheral pain signaling.</other>

<question_number>14</question_number>
<answer>$31 - pennies per pill (or a few dollars for a day's supply)</answer>
<other>Since the exact cost of the acetaminophen-hydrocodone combination per day is not given, we can't calculate the exact difference. However, the article does state that suzetrigine costs $31 a day and the older drug is "dirt cheap" at pennies per pill.</other>
<question_number>14</question_number>
<answer>N/A</answer>

<question_number>15</question_number>
<answer>2004</answer>

<other>The article states that in 2004, the Erythromelalgia Association told Dr. Waxman about a family in Alabama with "Man on Fire syndrome."</other>

<question_number>16</question_number>
<answer>lumbosacral radiculopathy</answer>

<other>The article mentions that suzetrigine was no better than placebo in those with pinched spinal nerves, which is related to lumbosacral radiculopathy.</other>

<question_number>17</question_number>
<answer>addiction</answer>

<other>The article explicitly mentions that suzetrigine is nonaddictive.</other>

<question_number>18</question_number>
<answer>a small proportion, specifically around 0.2125% (85,000 out of 40 million)</answer>
<other>Dr. Altshuler is quoted as saying that about 85,000 people a year become addicted after taking a prescription opioid out of 40 million prescribed.</other>
<question_number>18</question_number>
<answer>0.2125%</answer>

<question_number>19</question_number>
<answer>diabetic neuropathy</answer>

<other>The article states that Vertex found suzetrigine helped those with diabetic neuropathy.</other>